Statin treatment is not associated with a reduced risk of cardiovascular disease or death in healthy people older than 75 years, according to a study published in BMJ.
However, the study indicated that in patients with type II diabetes, the use of statins is associated with reduced risk of CVD and death before 85 years of age.
Thus, the authors of the study, conducted by the universities IDIAPJGol and IDIBGI, do not support the widespread use of statins in elderly patients, however, recommend their use in selected populations such as patients aged 75 – 84 years with type II diabetes.
Cardiovascular diseases are the most frequent cause of death worldwide, especially in patients older than 75 years. The purpose of statins in the last decade has increased, and the study confirmed the appropriateness of their admission as secondary prevention already diagnosed with CVD. However, the evidence of the effectiveness of statins as primary prevention is not enough.
All the news of the Russian and world medicine in our Telegram channel @MedicineNews.